Search Results
Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed
Search for other papers by Britt Skogseid in
Google Scholar
PubMed
Search for other papers by Johan Botling in
Google Scholar
PubMed
Search for other papers by Tobias Åkerström in
Google Scholar
PubMed
Search for other papers by Barbro Eriksson in
Google Scholar
PubMed
Search for other papers by Staffan Welin in
Google Scholar
PubMed
Search for other papers by Anders Sundin in
Google Scholar
PubMed
Search for other papers by Joakim Crona in
Google Scholar
PubMed
Epidemiology Guidelines ( 18 ). Study design, setting and participants This was a single-center retrospective cohort study at Uppsala University Hospital, Uppsala, Sweden. Patients were included when they fulfilled the following criteria: (i
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Weili Yin in
Google Scholar
PubMed
Search for other papers by Qiuxia Lin in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Yuanna Ling in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Zhen Li in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
amendments or comparable ethical standards. The need for informed consent was waived by the local ethics committee in view of the retrospective nature of the study. Results General characteristics Thirty-one patients (34.8%) met all three
Search for other papers by Arnaud Lagarde in
Google Scholar
PubMed
Search for other papers by Grégory Mougel in
Google Scholar
PubMed
Search for other papers by Lucie Coppin in
Google Scholar
PubMed
Search for other papers by Magalie Haissaguerre in
Google Scholar
PubMed
Inserm/CNRS UMR 1283/8199, Pasteur Institute of Lille, EGID, Lille, France
Search for other papers by Lauriane Le Collen in
Google Scholar
PubMed
Search for other papers by Amira Mohamed in
Google Scholar
PubMed
Search for other papers by Marc Klein in
Google Scholar
PubMed
Univ. Lille, Inserm, CHU Lille, U1286 – Infinite – Institute for Translational Research in Inflammation, Lille, France
Search for other papers by Marie-Françoise Odou in
Google Scholar
PubMed
Search for other papers by Antoine Tabarin in
Google Scholar
PubMed
Search for other papers by Hedia Brixi in
Google Scholar
PubMed
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Pauline Romanet in
Google Scholar
PubMed
number of false positives/kb. Cohort of unresolved MEN1 cases This study was performed on patients referred between March 2018 and March 2021 for MEN1 genetic testing to the molecular laboratory of Marseille La Conception Hospital. Patients
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
41416-019-0606-3 ) 24 Valent F Tullio A Kara E Cipri C Sciannimanico SM Vescini F & Grimaldi F . A retrospective cohort study of histology-proven neuroendocrine neoplasms in the Italian area of Udine . Endocrine, Metabolic and Immune
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Domenico Albano in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
Search for other papers by Luca Ceriani in
Google Scholar
PubMed
two consecutive Tg measurements under the thyroid hormone replacement therapy to calculate Tg kinetics; (ii) no interfering anti-Tg antibodies; (iii) prospective or retrospective studies. Information sources and search strategy A systematic
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Shanshan Yu in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Chun Liu in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
Patients From a retrospective review of the pathologic database at our institute between January 2015 and August 2020, 52 patients with PTL and 40 patients with DSVPTC were included in the study. Demographic, clinical and laboratory data were extracted
Search for other papers by Enrique Pedernera in
Google Scholar
PubMed
Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed
Search for other papers by María J Gómora in
Google Scholar
PubMed
Search for other papers by Miguel A Almaraz in
Google Scholar
PubMed
Universidad La Salle, Posgrado de la Facultad de Ciencias Químicas, Ciudad de México, México
Search for other papers by Esteban Mena in
Google Scholar
PubMed
Search for other papers by Delia Pérez-Montiel in
Google Scholar
PubMed
Search for other papers by Elizabeth Rendon in
Google Scholar
PubMed
Search for other papers by Horacio López-Basave in
Google Scholar
PubMed
Search for other papers by Juan Maldonado-Cubas in
Google Scholar
PubMed
Search for other papers by Carmen Méndez in
Google Scholar
PubMed
cohort study includes 111 patients diagnosed with primary epithelial ovarian tumor of Instituto Nacional de Cancerología at México City. The included cases spanned a decade from 2008 to 2018. None of the patients included received chemotherapy or
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany
Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed
Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed
Search for other papers by Burkhard Riemann in
Google Scholar
PubMed
Search for other papers by Maximilian Michel in
Google Scholar
PubMed
Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed
Search for other papers by Hakan Alakus in
Google Scholar
PubMed
Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed
time of diagnosis ( 1 ) which generally requires a systemic therapy in addition to surgery and/or radiation therapy. A recent single-institution retrospective study on 479 patients treated at the University of Texas MD Anderson Cancer Center over 20
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
). Changes in surveillance and treatment strategies in individual patients are mostly based on retrospective observations including observed tumor growth and symptom evolution. The next step toward personalized medicine is an aggregation of imaging
Search for other papers by Carole Morin in
Google Scholar
PubMed
Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
Search for other papers by Agathe Deville in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Search for other papers by Laurent Milot in
Google Scholar
PubMed
Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France
Search for other papers by Mathieu Pioche in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Gilles Poncet in
Google Scholar
PubMed
Search for other papers by Julien Forestier in
Google Scholar
PubMed
Search for other papers by Laurent François in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Mustapha Adham in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
populations initially managed within and outside the ENETS CoE have not yet been compared. Therefore, we designed a retrospective study, including all patients presented at least once in the MDT of Lyon-CoE for a new NEN diagnosis, which aims to assess the